Black Bird Biotech, Inc.
BBBT · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -69.5% | 75% | -38.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 36% | 54.1% | 45.8% | 12.5% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1,059.3% | -721.7% | -1,104.3% | -1,036.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,333.2% | -1,524.2% | -6,109.6% | -1,995.4% |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| % Growth | 66.7% | 70% | -25% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |